Ironwood Pharmaceuticals Inc Net Asset Quality Index
Ironwood Pharmaceuticals Inc net asset quality index. Ironwood Pharmaceuticals Inc (IRWD) has a Net Asset Quality Index of -56.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $285.13 Million minus total liabilities of $446.97 Million yields net assets of $-161.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Ironwood Pharmaceuticals Inc (IRWD) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Ironwood Pharmaceuticals Inc (2007–2025)
Net asset quality index of Ironwood Pharmaceuticals Inc from 2007 to 2025. This chart shows how Ironwood Pharmaceuticals Inc's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at -56.8%, representing net assets of $-161.84 Million against total assets of $285.13 Million USD. Check IRWD strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Ironwood Pharmaceuticals Inc Net Asset Quality Index by Year (2007–2025)
Ironwood Pharmaceuticals Inc net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Ironwood Pharmaceuticals Inc from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IRWD market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -66.0% | $-261.83 Million | $396.90 Million | $658.74 Million | ▲ +19.9 pp |
| 2024 | -85.9% | $-301.33 Million | $350.91 Million | $652.24 Million | ▼ -12.4 pp |
| 2023 | -73.5% | $-346.30 Million | $471.07 Million | $817.37 Million | ▼ -132.8 pp |
| 2022 | 59.3% | $652.38 Million | $1.10 Billion | $448.14 Million | ▲ +5.5 pp |
| 2021 | 53.8% | $605.91 Million | $1.13 Billion | $521.02 Million | ▲ +42.6 pp |
| 2020 | 11.2% | $62.64 Million | $559.24 Million | $496.60 Million | ▲ +34.4 pp |
| 2019 | -23.2% | $-93.25 Million | $402.75 Million | $496.00 Million | ▲ +36.0 pp |
| 2018 | -59.1% | $-196.37 Million | $332.05 Million | $528.42 Million | ▼ -60.8 pp |
| 2017 | 1.6% | $9.85 Million | $605.67 Million | $595.83 Million | ▼ -7.8 pp |
| 2016 | 9.4% | $66.72 Million | $709.82 Million | $643.11 Million | ▼ -6.0 pp |
| 2015 | 15.4% | $95.12 Million | $619.12 Million | $524.00 Million | ▼ -11.2 pp |
| 2014 | 26.6% | $88.55 Million | $333.51 Million | $244.96 Million | ▲ +12.8 pp |
| 2013 | 13.7% | $38.23 Million | $278.96 Million | $240.74 Million | ▼ -49.0 pp |
| 2012 | 62.7% | $144.05 Million | $229.91 Million | $85.86 Million | ▲ +10.1 pp |
| 2011 | 52.6% | $109.86 Million | $208.98 Million | $99.12 Million | ▼ -0.4 pp |
| 2010 | 52.9% | $159.55 Million | $301.37 Million | $141.81 Million | ▲ +236.6 pp |
| 2009 | -183.6% | $-298.34 Million | $162.45 Million | $460.79 Million | ▼ -19.9 pp |
| 2008 | -163.7% | $-230.41 Million | $140.72 Million | $371.13 Million | ▼ -32.5 pp |
| 2007 | -131.2% | $-178.37 Million | $135.91 Million | $314.28 Million | — |